Validated Clinical Evidence and Outcomes

Indicates that nearly one-third fewer patients required inpatient care, reflecting the program’s effectiveness at detecting and addressing COPD exacerbations early—before they escalate to hospital admissions.

Illustrates that when hospitalizations did occur, they were significantly shorter—cutting accumulated bed-days by over half and freeing up inpatient capacity for other high-need cases.

Demonstrates a substantial improvement in post-discharge stability, with readmission events falling by more than three-quarters—underscoring the value of continuous remote monitoring and follow-up care.

Reflects meaningful cost savings across the care continuum, translating into lower per-member expenditures by minimizing expensive acute-care events and optimizing outpatient management.